Cargando…
Flavonoid compound breviscapine suppresses human osteosarcoma Saos‐2 progression property and induces apoptosis by regulating mitochondria‐dependent pathway
This study was aimed to investigate the ability of a flavonoid compound breviscapine (BVP) to suppress growth and elicit apoptosis in human osteosarcoma (OS) Saos‐2 cells. The cells were cultured in vitro and treated with three concentrations of BVP (80, 160, and 320 μg/ml). Moreover, C57 mice were...
Autores principales: | Wang, Zhijun, Li, Hongyan, Yan, Jiyuan, Liu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816519/ https://www.ncbi.nlm.nih.gov/pubmed/32969555 http://dx.doi.org/10.1002/jbt.22633 |
Ejemplares similares
-
JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells
por: Choi, Dae Woo, et al.
Publicado: (2017) -
Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review
por: Gao, Jialiang, et al.
Publicado: (2017) -
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
por: Lan, Tian, et al.
Publicado: (2021) -
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
por: Chen, Yingchong, et al.
Publicado: (2020) -
Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone
por: Yen, Jia-Hau, et al.
Publicado: (2019)